SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Coram (CRH)--has the turnaround begun -- Ignore unavailable to you. Want to Upgrade?


To: leigh aulper who wrote (49)3/2/1999 9:22:00 AM
From: professor  Respond to of 85
 
Great news on Coram as they reported 2 cents for the quarter. Census was up, revenues up, EBITDA up. The turnaround is just beginning. This is a good sign for the industry as profits are starting to materialize again. CRH also announced they are entering the "E-Commerce" market by selling pharmacy products, supplies and services over the internet. CRH has an existing base of 40,000 patients who already purchase certain services and products from Coram. This will be an extension to allow Coram to sell other medical and pharmaceutical products to these patients and expand to other patients in the worldwide market. CRH actually has 55,600 patients so perhaps they can get the other 15,600 into the program as well. Given the earnings leverage that CRH has the interent business could be meaningful very quickly. If their patients start ordering a majority of their drugs through CRH's interent web site it could be extremely significant. The stock only trades at $1.875 and there are some smart investors involved like Richard Feinberg, Harrosh (sports magnate) and Goldman Sachs.